ESTUDIO DE FACTIBILIDAD LEGISLATIVA ENTRE MÉXICO Y ESTADOS UNIDOS PARA LA HABILITACIÓN DE UN ALMACÉN GENERAL DE DEPÓSITO

Un Almacén General de Depósito es una entidad dedicada al almacenamiento de bienes o mercancías bajo su custodia. Son los únicos facultados en México para la emisión de certificados y bonos de prenda, los cuales son reconocidos como instrumento financiero, el certificado es un título de garantía prendaria que acredita la propiedad y que describe el tipo de mercancía y valor de ésta, va acompañado de un bono de prenda y esté es la constitución de un crédito prendario sobre las mercancías o bienes indicados en el certificado de depósito [1]. El artículo presenta una revisión de la literatura que tienecomo objetivo conocer la constitución legislativa de los Almacenes Generales de Depósito en México e investigarel modelo de estos en El Paso Texas, y su legislación, además de conocer temas de apoyo que aportan a la investigación como la internacionalización de las empresas. Para ello se realizó una búsqueda sistemática de artículosobteniendo 60 hallazgos de temas de interés, de los cualessolo 17 con aportación directa al tema de investigación, 8 artículos con información respecto a las leyes legislativas en otros países para la apertura de un almacén general dedepósito y 9 artículos que sustentan lainternacionalización de las empresas de México hacia Estados Unidos. Se consultaron además normativas de Estados Unidos y México. Se identificó la existencia de los Almacenes Generales de Depósito en México, Centro América, Sur América y Europa y su instrumento financiero el “warrant”. Así mismo las teorías para la expansión de una empresa hacia Estados Unidos destacando la propia teoría de la internacionalización de las empresas

Differential Carbon Catabolite Repression and Hemicellulolytic Ability among Pathotypes of <i>Colletotrichum lindemuthianum</i> against Natural Plant Substrates

Colletotrichum lindemuthianum is a phytopathogenic fungus that causes anthracnose in common beans (Phaseolus vulgaris) and presents a great diversity of pathotypes with different levels of virulence against bean varieties worldwide. The purpose of this study was to establish whether pathotypic diversity is associated with differences in the mycelial growth and secretion of plant-cell-wall-degrading enzymes (PCWDEs). We evaluated growth, hemicellulase and cellulase activity, and PCWDE secretion in four pathotypes of C. lindemuthianum in cultures with glucose, bean hypocotyls and green beans of P. vulgaris, and water hyacinth (Eichhornia crassipes). The results showed differences in the mycelial growth, hemicellulolytic activity, and PCWDE secretion among the pathotypes. Glucose was not the preferred carbon source for the best mycelial growth in all pathotypes, each of which showed a unique PCWDE secretion profile, indicating different levels of carbon catabolite regulation (CCR). The pathotypes showed a high differential hemicellulolytic capacity to degrade host and water hyacinth tissues, suggesting CCR by pentoses and that there are differences in the absorption and metabolism of different monosaccharides and/or disaccharides. We propose that different levels of CCR could optimize growth in different host tissues and could allow for consortium behavior in interactions with bean crops

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN